Seven Eight Capital LP Takes Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Seven Eight Capital LP acquired a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 9,902 shares of the company’s stock, valued at approximately $669,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Blue Trust Inc. increased its stake in shares of Acadia Healthcare by 86.1% in the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after acquiring an additional 248 shares during the last quarter. Mather Group LLC. bought a new stake in Acadia Healthcare in the first quarter valued at approximately $48,000. nVerses Capital LLC acquired a new stake in Acadia Healthcare in the second quarter worth $95,000. Innealta Capital LLC bought a new position in shares of Acadia Healthcare during the second quarter worth $164,000. Finally, Capstone Investment Advisors LLC acquired a new position in shares of Acadia Healthcare in the 4th quarter valued at $204,000.

Analyst Ratings Changes

Several analysts recently commented on ACHC shares. Barclays dropped their price objective on Acadia Healthcare from $89.00 to $83.00 and set an “overweight” rating on the stock in a research note on Thursday, August 1st. Royal Bank of Canada reiterated an “outperform” rating and set a $94.00 price objective on shares of Acadia Healthcare in a report on Friday. Cantor Fitzgerald reissued a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a research note on Monday, August 19th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, Acadia Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $87.44.

Acadia Healthcare Stock Down 1.3 %

Acadia Healthcare stock opened at $76.40 on Friday. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a 1-year low of $62.04 and a 1-year high of $87.77. The company has a fifty day simple moving average of $73.53 and a 200 day simple moving average of $71.97. The company has a market cap of $7.09 billion, a P/E ratio of -545.71, a price-to-earnings-growth ratio of 2.22 and a beta of 1.30.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. The business had revenue of $796.00 million for the quarter, compared to the consensus estimate of $784.38 million. During the same quarter in the previous year, the business earned $0.92 earnings per share. Acadia Healthcare’s quarterly revenue was up 8.8% on a year-over-year basis. Research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.51 earnings per share for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.